Schrader E, Hirsch-Ernst K I, Richter E, Foth H
Institute of Toxicology, University of Göttingen, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1998 Mar;357(3):336-43. doi: 10.1007/pl00005176.
The tobacco specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a strong lung carcinogen in all species tested. To elicit its tumorigenic effects NNK requires metabolic activation which is supposed to take place via alpha-hydroxylation, whereas N-oxidation is suggested to be a detoxification pathway. The differences in the organ specific metabolism of NNK may be crucial for the organotropy in NNK-induced carcinogenesis. Therefore, metabolism of NNK was investigated in the target organ lung and in liver of Fischer 344 (F344) rats using the model of isolated perfused organs. High activity to metabolize 35 nM [5-3H]NNK was observed in both perfused organs. NNK was eliminated by liver substantially faster (clearance 6.9 +/- 1.6 ml/min, half-life 14.6 +/- 1.2 min) than by lung (clearance 2.1 +/- 0.5 ml/min, half-life 47.9 +/- 7.4 min). When the clearance is calculated for a gram of organ or for metabolically active cell forms, the risk with respect to carcinogenic mechanisms was higher in lung than in liver. The metabolism of NNK in liver yielded the two products of NNK alpha-hydroxylation, the 4-oxo-4-(3-pyridyl)-butyric acid (keto acid) and 4-hydroxy-4-(3-pyridyl)-butyric acid (hydroxy acid). In lung, the major metabolite of NNK was 4-(methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanone (NNK-N-oxide). Substantial amounts of metabolites formed from methyl hydroxylation of NNK, which is one of the two possible pathways of alpha-hydroxylation, were detected in lung but not in liver perfusion. Formation of these metabolites (4-oxo-4-(3-pyridyl)-butanol (keto alcohol), and 4-hydroxy-4-(3-pyridyl)-butanol (diol) can give rise to pyridyloxobutylating of DNA. When isolated rat livers were perfused with 150 microM NNK, equal to a dosage which is sufficient to induce liver tumors in rat, glucuronidation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) was increased when compared to the concentration of 35 nM NNK. Nevertheless, the main part of NNK was also transformed via alpha-hydroxylation for this high concentration of NNK.
烟草特异亚硝胺4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁酮(NNK)在所有受试物种中都是一种强力肺致癌物。为发挥其致癌作用,NNK需要代谢活化,推测其通过α-羟基化发生,而N-氧化被认为是一条解毒途径。NNK器官特异性代谢的差异可能对NNK诱导致癌过程中的器官otropy至关重要。因此,使用离体灌注器官模型,在Fischer 344(F344)大鼠的靶器官肺和肝脏中研究了NNK的代谢。在两个灌注器官中均观察到代谢35 nM [5-3H]NNK的高活性。肝脏对NNK的清除速度(清除率6.9±1.6 ml/min,半衰期14.6±1.2 min)明显快于肺(清除率2.1±0.5 ml/min,半衰期47.9±7.4 min)。当按每克器官或代谢活性细胞形式计算清除率时,肺在致癌机制方面的风险高于肝脏。NNK在肝脏中的代谢产生了NNKα-羟基化的两种产物,4-氧代-4-(3-吡啶基)-丁酸(酮酸)和4-羟基-4-(3-吡啶基)-丁酸(羟酸)。在肺中,NNK的主要代谢产物是4-(甲基亚硝胺基)-1-(3-吡啶基-N-氧化物)-1-丁酮(NNK-N-氧化物)。在肺灌注中检测到大量由NNK甲基羟基化形成的代谢产物,甲基羟基化是α-羟基化的两种可能途径之一,但在肝脏灌注中未检测到。这些代谢产物(4-氧代-4-(3-吡啶基)-丁醇(酮醇)和4-羟基-4-(3-吡啶基)-丁醇(二醇))的形成可导致DNA的吡啶氧基丁基化。当用150 microM NNK灌注离体大鼠肝脏时,与35 nM NNK的浓度相比,4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁醇(NNAL)的葡萄糖醛酸化增加。然而,对于这种高浓度的NNK,NNK的主要部分也通过α-羟基化进行了转化。